Across the past 12 months, open-market trades by Protara Therapeutics insiders were all sales, totaling $1.01 million (239.42K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Management Inc. Opaleye | TenPercentOwner | 0 | 1,989,134 | 1,989,134 | 59.3% | 12 Sep, 2024 |
| 2 | Jesse Shefferman | Ceo And President | 691,832 | 0 | 691,832 | 20.6% | 01 Jul, 2026 |
| 3 | Luke M Beshar | Director | 198,000 | 0 | 198,000 | 5.9% | 05 Jul, 2022 |
| 4 | Jacqueline Zummo | Chief Rd Officer | 94,827 | 0 | 94,827 | 2.8% | 09 Apr, 2026 |
| 5 | Leonardo Viana Nicacio | Chief Medical Officer | 78,181 | 0 | 78,181 | 2.3% | 21 Jan, 2026 |
| 6 | William Conkling | Chief Commercial Officer | 69,992 | 0 | 69,992 | 2.1% | 03 Jun, 2026 |
| 7 | Patrick Fabbio | Chief Financial Officer | 64,115 | 0 | 64,115 | 1.9% | 27 Jan, 2026 |
| 8 | Jathin Bandari | Chief Medical Officer | 56,704 | 0 | 56,704 | 1.7% | 23 Jan, 2024 |
| 9 | Richard S Levy | Director | 51,000 | 0 | 51,000 | 1.5% | 19 May, 2025 |
| 10 | Hannah Fry | Vp, Controller | 42,723 | 0 | 42,723 | 1.3% | 27 Jan, 2026 |
| 11 | Blaine Davis | Chief Financial Officer | 20,662 | 0 | 20,662 | 0.6% | 19 Jul, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 29 Jun, 2026 | Jesse Shefferman | Ceo And President | Acquired M | 215,687 | $1.91 | $411.96K | 937,519 | Direct |
| 29 Jun, 2026 | Jesse Shefferman | Ceo And President | Disposed S | 215,687 | $4.09 | $882.16K | 721,832 | Direct |
| 30 Jun, 2026 | Jesse Shefferman | Ceo And President | Disposed G | 14,000 | $0.00 | $0 | 707,832 | Direct |
| 30 Jun, 2026 | Jesse Shefferman | Ceo And President | Disposed G | 7,000 | $0.00 | $0 | 700,832 | Direct |
| 30 Jun, 2026 | Jesse Shefferman | Ceo And President | Disposed G | 4,000 | $0.00 | $0 | 696,832 | Direct |
| 30 Jun, 2026 | Jesse Shefferman | Ceo And President | Disposed G | 5,000 | $0.00 | $0 | 691,832 | Direct |
| 29 Jun, 2026 | Jesse Shefferman | Ceo And President | Disposed M | 215,687 | $0.00 | $0 | 141,313 | Direct |
| 15 Jun, 2026 | Jane Huang | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Barry P Flannelly | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Richard S Levy | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Roger Garceau | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Cynthia Smith | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Gregory Sargen | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Michael Edward Solomon | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 15 Jun, 2026 | Luke M Beshar | Director | Acquired A | 31,000 | $0.00 | $0 | 31,000 | Direct |
| 02 Jun, 2026 | William Conkling | Chief Commercial Officer | Disposed F | 6,008 | $4.34 | $26.07K | 69,992 | Direct |
| 08 Apr, 2026 | Jacqueline Zummo | Chief Rd Officer | Disposed S | 1,134 | $5.40 | $6.12K | 94,827 | Direct |
| 01 Apr, 2026 | Jacqueline Zummo | Chief Rd Officer | Disposed S | 22,598 | $5.26 | $118.87K | 95,961 | Direct |
| 26 Jan, 2026 | Jesse Shefferman | Ceo And President | Disposed F | 8,732 | $6.67 | $58.24K | 1,021,832 | Direct |
| 26 Jan, 2026 | Jacqueline Zummo | Chf Scientific Operations Off | Disposed F | 3,724 | $6.67 | $24.84K | 118,559 | Direct |